Stem definition | Drug id | CAS RN |
---|---|---|
hypoxia inducible factor (HIF) prolyl hydroxylase inhibitors | 5420 | 1000025-07-9 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
April 24, 2023 | EMA | AKEBIA EUROPE LIMITED | |
June 29, 2020 | PMDA | Mitsubishi Tanabe Pharma |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | B03XA08 | BLOOD AND BLOOD FORMING ORGANS ANTIANEMIC PREPARATIONS OTHER ANTIANEMIC PREPARATIONS Other antianemic preparations |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Anemia of renal disease | indication | 234348004 | |
Anemia in chronic kidney disease | indication | 707323002 |
None
None
None
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Egl nine homolog 1 | Enzyme | INHIBITOR | IC50 | 7.81 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
Egl nine homolog 2 | Enzyme | INHIBITOR | IC50 | 7.93 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
Egl nine homolog 3 | Enzyme | INHIBITOR | IC50 | 8.12 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
Vascular endothelial growth factor A | Secreted | EC50 | 5.12 | CHEMBL | |||||
Hypoxia-inducible factor 1-alpha inhibitor | Enzyme | IC50 | 4.54 | CHEMBL | |||||
Prolyl 3-hydroxylase OGFOD1 | Unclassified | IC50 | 5.85 | CHEMBL | |||||
Prolyl 4-hydroxylase | Unclassified | Ki | 6.55 | CHEMBL |
ID | Source |
---|---|
D11078 | KEGG_DRUG |
I60W9520VV | UNII |
C4519730 | UMLSCUI |
A1Z | PDB_CHEM_ID |
CHEMBL3646221 | ChEMBL_ID |
23634441 | PUBCHEM_CID |
DB12255 | DRUGBANK_ID |
11831 | IUPHAR_LIGAND_ID |
C000624313 | MESH_SUPPLEMENTAL_RECORD_UI |
10289 | INN_ID |
None